1. INTRODUCTION
1.1. MARKET DEFINITION
1.2. MARKET SEGMENTATION
1.3. PRODUCT OVERVIEW
2. ASSUMPTIONS AND ACRONYMS
3. RESEARCH METHODOLOGY
3.1. VARIABLES (DEPENDENT AND INDEPENDENT)
3.2. MULTI FACTOR BASED SENSITIVITY MODEL
4. EXECUTIVE SUMMARY - NORTH AMERICA, SOUTH AMERICA, AND CHINA COMPANION ANIMAL DIAGNOSTICS MARKET
5. INDUSTRY ANALYSIS
5.1. RISK ANALYSIS
5.1.1. DEMAND RISK ANALYSIS
5.1.2. SUPPLY RISK ANALYSIS
5.2. REGULATORY LANDSCAPE
6. MARKET DYNAMICS
6.1. DRIVERS
6.2. RESTRAINTS
6.3. OPPORTUNITIES
6.4. TRENDS
7. NORTH AMERICA, SOUTH AMERICA, AND CHINA COMPANION ANIMAL DIAGNOSTICS MARKET OUTLOOK
7.1. MARKET SIZE AND FORECAST, 2018-2027
7.1.1. BY VALUE (USD MILLION)
7.2. NORTH AMERICA, SOUTH AMERICA, AND CHINA COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
7.2.1. BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
· BY APPLICATION, 2018-2027F (USD MILLION)
§ CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§ IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
7.2.2. BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
8. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET OUTLOOK
8.1. MARKET SIZE AND FORECAST, 2018-2027
8.1.1. BY VALUE (USD MILLION)
8.2. MACROECONOMIC INDICATORS, BY COUNTRY
8.3. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
8.3.1. BY COUNTRY
8.3.1.1. US, 2018-2027F (USD MILLION)
Ø BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
· BY APPLICATION, 2018-2027F (USD MILLION)
§ CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§ IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
Ø BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
8.3.1.2. CANADA, 2018-2027F (USD MILLION)
Ø BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
· BY APPLICATION, 2018-2027F (USD MILLION)
§ CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§ IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
Ø BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
8.3.1.3. MEXICO, 2018-2027F (USD MILLION)
Ø BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
·BY APPLICATION, 2018-2027F (USD MILLION)
§ CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§ IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
Ø BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
9. SOUTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET OUTLOOK
9.1. MARKET SIZE AND FORECAST, 2018-2027
9.1.1. BY VALUE (USD MILLION)
9.2. MACROECONOMIC INDICATORS, BY COUNTRY
9.3. SOUTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
9.3.1. BY COUNTRY
9.3.1.1. BRAZIL, 2018-2027F (USD MILLION)
Ø BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
· BY APPLICATION, 2018-2027F (USD MILLION)
§CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
Ø BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
9.3.1.2. REST OF SOUTH AMERICA, 2018-2027F (USD MILLION)
Ø BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
· BY APPLICATION, 2018-2027F (USD MILLION)
§CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§ IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
Ø BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
10. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET OUTLOOK
10.1. MARKET SIZE AND FORECAST, 2018-2027
10.1.1. BY VALUE (USD MILLION)
10.2. MACROECONOMIC INDICATORS
10.3. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
Ø BY PROCEDURE, 2018-2027F (USD MILLION)
o IN-VITRO DIAGNOSTIC, 2018-2027F (USD MILLION)
· BY APPLICATION, 2018-2027F (USD MILLION)
§ CLINICAL PATHOLOGY, BACTERIOLOGY, VIROLOGY, PARASITOLOGY, OTHERS, 2018-2027F (USD MILLION)
· BY COMPONENT, 2018-2027F (USD MILLION)
§ ANALYZERS & EQUIPMENT, REAGENTS, 2018-2027F (USD MILLION)
· BY TECHNOLOGY, 2018-2027F (USD MILLION)
§ IMMUNODIAGNOSTICS, HEMATOLOGY, URINALYSIS, MOLECULAR DIAGNOSTICS, OTHERS, 2018-2027F (USD MILLION)
o DIAGNOSTIC IMAGING, 2018-2027F (USD MILLION)
· X-RAY, MRI, CT SCAN, ULTRASOUND, OTHERS, 2018-2027F (USD MILLION)
o MONITORING, 2018-2027F (USD MILLION)
· RESPIRATORY MONITORING EQUIPMENT, CARDIAC MONITORING EQUIPMENT, NEUROLOGICAL MONITORING EQUIPMENT, VITAL SIGNS MONITORING EQUIPMENT, OTHERS, 2018-2027F (USD MILLION)
Ø BY END USER , 2018-2027F (USD MILLION)
o VETERINARY HOSPITALS, VETERINARY CLINICS, ACADEMIC INSTITUTIONS, OTHERS, 2018-2027F (USD MILLION)
11. COMPETITIVE STRUCTURE
11.1. DETAILED OVERVIEW
11.2. ASSESSMENT OF KEY PRODUCT OFFERINGS
11.3. ANALYSIS OF GROWTH STRATEGIES
11.4. EXHAUSTIVE ANALYSIS ON KEY FINACIAL INDICATORS
11.5. REGIONAL PRESENCE
11.6. RECENT DEVELOPMENTS
11.7. COMPETITIVE POSITIONING
11.8. COMPANY PROFILES
· SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
· ZOETIS
· THERMO FISCHER SCIENTIFIC
· IDEXX
· MEDTRONIC INC.
· QIAGEN
· HESKA CORPORATION
· NEOGEN CORPORATION
OTHER PROMINENT PLAYERS
12. STRATEGY RECCOMENDATIONS
